Bumper Offer - Urjas oil Just @ Rs. 1
Zipod 50 Mg Dry Syrup is a commercial drug that is prescribed in the form of Syrup. It is primarily used for the treatment of Urinary Tract Infection, Bronchitis. Other than this, Zipod 50 Mg Dry Syrup has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Zipod 50 Mg Dry Syrup depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Zipod 50 Mg Dry Syrup as well, which are listed below. Usually, these side effects of Zipod 50 Mg Dry Syrup go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Zipod 50 Mg Dry Syrup has a Mild effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Zipod 50 Mg Dry Syrup related warnings talks about Zipod 50 Mg Dry Syrup's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Zipod 50 Mg Dry Syrup contraindications section.
Additionally, Zipod 50 Mg Dry Syrup may also adversely react with other medicines. See below for a complete list.
You should also be aware that Zipod 50 Mg Dry Syrup is safe while driving, and is addiction.
Zipod 50 Mg Dry Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Zipod 50 Mg Dry Syrup is used -
Moderate
Mild
Is the use of Zipod 50 Mg Dry Syrup safe for pregnant women?
Zipod rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Zipod 50 Mg Dry Syrup safe during breastfeeding?
Zipod can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Zipod 50 Mg Dry Syrup on the Kidneys?
There may be some adverse effects on kidney after taking Zipod. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Zipod 50 Mg Dry Syrup on the Liver?
There may be an adverse effect on the liver after taking Zipod. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Zipod 50 Mg Dry Syrup on the Heart?
Zipod may have mild side effects on the heart. Most people will never see any effect on the heart.
Zipod 50 Mg Dry Syrup should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zipod 50 Mg Dry Syrup unless your doctor advises you to do so -
Is this Zipod 50 Mg Dry Syrup habit forming or addictive?
No, there is no any evidence that Zipod 50 Mg Dry Syrup is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Zipod 50 Mg Dry Syrup as it does not make you drowsy.
Is it safe?
Yes, Zipod 50 Mg Dry Syrup does not show any kind of adverse effect.
Is it able to treat mental disorders?
No, Zipod 50 Mg Dry Syrup cannot treat any kind of mental disorder.
Interaction between Food and Zipod 50 Mg Dry Syrup
You can take Zipod 50 Mg Dry Syrup with food.
Interaction between Alcohol and Zipod 50 Mg Dry Syrup
Information about the interaction of Zipod 50 Mg Dry Syrup and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311